Safety
-
Amevive (alefacept)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – May 2012
6 ADVERSE REACTIONS
6.3 Postmarketing Experience
- sections added ..... malignancies and serious infections
MEDICATION GUIDE
- new
-
-







